Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Repligen Corporation - Common Stock
(NQ:
RGEN
)
145.66
+2.84 (+1.99%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
896,249
Open
144.40
Bid (Size)
145.65 (500)
Ask (Size)
145.74 (500)
Prev. Close
142.82
Today's Range
144.40 - 151.10
52wk Range
102.97 - 182.52
Shares Outstanding
55,679,964
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN)
November 06, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Repligen (NASDAQ:RGEN) and its peers.
Via
StockStory
5 Revealing Analyst Questions From Repligen’s Q3 Earnings Call
November 04, 2025
Repligen’s third quarter saw revenue and non-GAAP profit exceed Wall Street expectations, yet the market responded negatively. Management attributed the quarter’s strong top-line performance to...
Via
StockStory
Topics
Earnings
Performance
YTD
+1.8%
+1.8%
1 Month
-2.0%
-2.0%
3 Month
+30.2%
+30.2%
6 Month
+8.9%
+8.9%
1 Year
+4.4%
+4.4%
More News
Read More
3 Hyped Up Stocks with Open Questions
October 30, 2025
Via
StockStory
Earnings Scheduled For October 28, 2025
October 28, 2025
Via
Benzinga
RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset
October 29, 2025
Via
StockStory
Why Repligen (RGEN) Shares Are Trading Lower Today
October 28, 2025
Via
StockStory
Topics
Economy
Government
World Trade
Repligen Corp (NASDAQ:RGEN) Posts Strong Q3 2025 Results, Beating Revenue and EPS Estimates
October 28, 2025
Via
Chartmill
Repligen’s (NASDAQ:RGEN) Q3 Sales Beat Estimates
October 28, 2025
Via
StockStory
Topics
Earnings
Repligen Earnings: What To Look For From RGEN
October 26, 2025
Via
StockStory
Topics
Artificial Intelligence
3 Inflated Stocks with Questionable Fundamentals
October 21, 2025
Via
StockStory
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know
October 10, 2025
Via
StockStory
Topics
Economy
Government
World Trade
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
October 01, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
October 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Credit Cards
What 8 Analyst Ratings Have To Say About Repligen
October 01, 2025
Via
Benzinga
Why Is Repligen (RGEN) Stock Soaring Today
October 01, 2025
Via
StockStory
Topics
Government
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
September 30, 2025
Via
StockStory
Topics
Government
1 Volatile Stock to Target This Week and 2 Facing Challenges
September 25, 2025
Via
StockStory
3 Reasons to Sell RGEN and 1 Stock to Buy Instead
September 24, 2025
Via
StockStory
Topics
Stocks
Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)
September 22, 2025
Via
StockStory
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
September 22, 2025
Via
Benzinga
Small-Cap and Value Stocks Stage a Powerful Comeback: A Market Rebalancing Act Underway
September 19, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Repligen (RGEN) Stock Is Up, What You Need To Know
September 16, 2025
Via
StockStory
Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power
September 15, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
1 Cash-Producing Stock with Exciting Potential and 2 We Avoid
September 13, 2025
Via
StockStory
Why Repligen (RGEN) Stock Is Down Today
September 12, 2025
Via
StockStory
Topics
Artificial Intelligence
Economy
Frequently Asked Questions
Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 145.66
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 11/10/25 04:00 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 8.11B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.